Evidence map›Paper›PMID 29998520›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2019

ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.

A G A Kolios, A J Hueber, P Michetti, U Mrowietz, M Mustak-Blagusz, P-G Sator, M Reinshagen, D Wilsmann-Theis, S Gomis-Kleindienst, U Luckey and 2 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 4 countries.

A G A KoliosDepartments of Immunology and Dermatology, University Hospital Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3897-4578
A J HueberDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
P MichettiGastroentérologie La Source-Beaulieu and Division of Gastroenterology, Centre hospitalier Universitaire Vaudois, Lausanne, Switzerland.
U MrowietzPsoriasis Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany.ORCID http://orcid.org/0000-0002-9539-0712
M Mustak-BlaguszRehabilitation Center, Gröbming, Austria.
P-G SatorDepartment of Dermatology, Hospital Hietzing, Vienna, Austria.
M ReinshagenDepartment of Medicine I, Klinikum Braunschweig, Braunschweig, Germany.
D Wilsmann-TheisDepartment of Dermatology and Allergy, University Bonn, Bonn, Germany.
S Gomis-KleindienstMedical Department, AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany.
U LuckeyMedical Department, AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany.
A RösslerMedical Department, AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany.
I SchiefkeDepartment of Gastroenterology, Hepatology, Endocrinology and Diabetology, St. George Hospital, Leipzig, Germany.
AbbVie (Germany) · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEKlinik Hietzing · ATKlinikum Braunschweig · DEUniversity Hospital Leipzig · DEUniversity Hospital of Lausanne · CHUniversity Hospital Schleswig-Holstein · DEUniversity of Bonn · DEUniversity of Zurich · CH

Funding

AbbVie Inc.
6 · The paper itself

Abstract

backgroundNon-adherence to medication is a challenging problem in daily clinical practice.

objectiveTo assess reasons for non-adherence in patients with chronic immune-mediated inflammatory diseases (IMIDs) in a direct comparison including evaluation of treatment necessity and concerns.

methodsALIGN was a non-interventional, multicountry, multicentre, self-administered, cross-sectional, epidemiologic survey study. Here, we investigate the German, Austrian and Swiss (DACH) cohort. Six hundred thirty-one patients with different IMIDs (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease and ulcerative colitis) under systemic therapies were evaluated concerning adherence, beliefs of necessity and concerns towards treatment in patients with IMIDs.

resultsThe DACH cohort had significantly different levels of adherence depending on the IMID (P < 0.05) and the type of therapy (P < 0.05). Based on the significant influence of concerns on treatment adherence (P < 0.05) and the high belief of treatment necessity, patients could be classified in four attitudinal segments, which were unequally distributed throughout various IMIDs. High concerns had a significant influence on non-adherence, whereas necessity did not. Older age, female sex, TNFi mono-, conventional combination and TNFi combination therapy are positively associated with adherence.

conclusionsIn the DACH region, patients are less concerned about medication and believe in the necessity of treatment. Therefore, we suggest adapting the communication in the various patient groups.

Indexed as

Health Knowledge, Attitudes, PracticeAdultAgedAged, 80 and overAge FactorsAntirheumatic AgentsArthritisArthritis, PsoriaticArthritis, RheumatoidAustriaColitis, UlcerativeCrohn DiseaseCross-Sectional StudiesDermatologic AgentsFemaleGastrointestinal AgentsAntirheumatic AgentsDermatologic AgentsGastrointestinal AgentsTumor Necrosis Factor-alpha

Identifiers

PMID29998520
PMCPMC6585659
OpenAlexW2813167996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.